newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics Announces Pricing of Initial Public Offering

BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe